Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,237 CHF | +0.78% | +0.28% | +21.61% |
May. 29 | GIVAUDAN AG : JP Morgan remains Neutral | ZD |
May. 28 | GIVAUDAN AG : Deutsche Bank reiterates its Neutral rating | ZD |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company returns high margins, thereby supporting business profitability.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 39.73 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+21.61% | 43.27B | B+ | ||
+17.07% | 66.31B | A- | ||
-0.29% | 48.46B | A- | ||
+26.72% | 27.41B | A- | ||
+9.25% | 19.26B | C+ | ||
-2.14% | 16.61B | B+ | ||
+9.75% | 16.58B | B+ | ||
-15.01% | 14.41B | C+ | ||
-30.22% | 14.02B | A- | ||
-22.45% | 13.34B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GIVN Stock
- Ratings Givaudan SA